Shao, W.; Kuhn, C.; Mayr, D.; Ditsch, N.; Kailuweit, M.; Wolf, V.; Harbeck, N.; Mahner, S.; Jeschke, U.; Cavaillès, V.;
et al. Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer. Int. J. Mol. Sci. 2020, 21, 330.
https://doi.org/10.3390/ijms21010330
AMA Style
Shao W, Kuhn C, Mayr D, Ditsch N, Kailuweit M, Wolf V, Harbeck N, Mahner S, Jeschke U, Cavaillès V,
et al. Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer. International Journal of Molecular Sciences. 2020; 21(1):330.
https://doi.org/10.3390/ijms21010330
Chicago/Turabian Style
Shao, Wanting, Christina Kuhn, Doris Mayr, Nina Ditsch, Magdalena Kailuweit, Verena Wolf, Nadia Harbeck, Sven Mahner, Udo Jeschke, Vincent Cavaillès,
and et al. 2020. "Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer" International Journal of Molecular Sciences 21, no. 1: 330.
https://doi.org/10.3390/ijms21010330
APA Style
Shao, W., Kuhn, C., Mayr, D., Ditsch, N., Kailuweit, M., Wolf, V., Harbeck, N., Mahner, S., Jeschke, U., Cavaillès, V., & Sixou, S.
(2020). Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer. International Journal of Molecular Sciences, 21(1), 330.
https://doi.org/10.3390/ijms21010330